BA vs MRK: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-07.
The Boeing Company · Industrials
$234.54
+45.0% upside to fair value
Grade C
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
MRK |
| Current Price |
$234.54 |
$113.87 |
| Fair Value Estimate |
$340.08 |
$100.14 |
| Upside to Fair Value |
+45.0%
|
-12.1%
|
| Market Cap |
$184.9B |
$281.2B |
| Forward P/E |
96.9x
|
32.0x
|
| EV / EBITDA |
30.4x
|
17.3x
|
| Price / Sales |
2.0x
|
4.3x
|
| Price / FCF |
-177.6x
|
19.9x
|
| Revenue Growth YoY |
+14.0%
|
+4.3%
|
| Gross Margin |
4.8%
|
75.9%
|
| Operating Margin |
-5.9%
|
27.6%
|
| Return on Equity |
-8723.1%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
The Boeing Company operates in the Industrials sector within the Aerospace & Defense industry, manufacturing commercial jetliners, defense, space, and security systems. Despite a challenging operating margin of -5.9% and a negative free cash flow per share of -2.46, Boeing shows strong recent earnings growth of 89.2% and revenue growth of 14.0% in the most recent quarter, signaling a potential re…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
BA |
MRK |
| Zone Low |
$255.06 |
$75.11 |
| Zone High |
$289.07 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|